HIV Nursing 2019 will take place September 21-22, 2019, in Rome.
HIV Nursing 2019 will offer an opportunity for discussion, debate, and networking as nurses from around the world collectively work to improve the prevention, care, treatment, and support services delivered to people affected by HIV. Moreover, the conference will focus on the role of nurse clinical leadership in supporting global programmatic targets (90-90-90) and the Sustainable Development Goal of ending AIDS as a public health threat.
HIV Nursing 2019 will be sponsored by the International Association of Providers of AIDS Care (IAPAC) in partnership with the European HIV Nursing Network (EHNN), the National HIV Nursing Association (NHIVNA), and the Association of Nurses in AIDS Care (ANAC). The conference Co-Chairs are Ian Hodgson, PhD, RN, MA (European HIV Nursing Network, London, England), Michelle Croston, RGN, RHV (Manchester Metropolitan University, Manchester, England); and Carole Treston, RN, MPH (Association of Nurses in AIDS Care, Washington, DC, USA).
Following are key dates relevant to registration, abstract submissions, and venue/accommodations:
- Early Registration Deadline – May 31, 2019
- Abstract Submission Deadline – May 3, 2019
- Abstract Disposition Announcements – June 7, 2019
- Standard Registration Deadline – July 26, 2019
- Hotel Accommodations Deadline – TBD
- Cancellation Deadline (with €50 penalty) – August 2, 2019
Since the beginning of the HIV epidemic, nurses have been on the front lines of care delivery. Nurses are ideally placed to promote and deliver high quality HIV prevention, care, and treatment that meets the needs of affected people and maximizes health outcomes for most at-risk individuals. HIV Nursing 2019 will provide nurses with evidence-based education on best practices and future directions in managing HIV and its comorbidities.
Among the topics to be covered in plenaries or panel discussions at this year’s conference include:
- The Role of Nurses in Human Rights and Social Justice
- The Nurses’ Role in Generating Demand and Facilitating Uptake of PrEP
- HIV Nursing in Support of HIV Epidemic Control
- Women and HIV: Optimizing Outreach, Care, and Support
- Beyond Antiretrovirals: Aging, Comorbidities, and Quality of Life
- Mental Health, HIV, and HCV: Scaling Up Nurse-Led/-Facilitated Interventions
- Controlling the HIV Epidemic: What Role Should Nurses Play?
The conference will also feature six case study-based sessions covering lifestyle counseling, psychological care, self-management strategies, reproductive health, substance users, and men who have sex with men. In addition, the conference will include professional development workshops for first-level and advanced practice nurses.
The program will be regularly updated with confirmed faculty members.
Venue and Accommodations
Hotel Quirinale is the venue for HIV Nursing 2019.
A set of discounted hotel rooms have been reserved for the nights of September 20-23, 2019. A Double Room (for single use) is available for €215/night (inclusive of breakfast buffet and 10% VAT).
The room block has limited availability on a first-come, first-served basis. Information regarding how to make a hotel room reservation will be forthcoming soon.
Via Nazionale, 7
00184 Rome, Italy
Tel: +39 06 4707
Fax: +39 06 4820099
Submit an Abstract
Following are some general guidelines for individuals interested in submitting an abstract(s):
- The abstract must NOT contain more than 300 words.
- Acceptable abstracts shall contain a concise statement of the research, define the precise subject of the presentation, and be related to the main theme or a sub-theme of the conference.
- Tables, figures, literature references, and acknowledgements should not form any part of the abstract’s content.
- The author is responsible for all grammatical and factual details. You may edit your abstract after it has been submitted.
- All abstracts must be submitted in English. If you are not fluent in English, please attempt to have your abstract reviewed by a fluent English speaker.
- Define all abbreviations and concepts in your abstract at first use.
- For therapeutic agents, only generic names may be used (trade names are not permitted).
ABSTRACT SUBMISSION AND ACCEPTANCE
The abstract submission deadline is 5:00 pm EDT, Friday, May 3, 2019. All abstracts must be submitted online, and all submissions will be acknowledged upon successful submission via the site. Faxed or mailed abstracts will not be considered.
Please record your abstract number. The number assigned to your abstract when it is submitted online will be the abstract number referenced throughout the conference, including in the Program and Abstracts book and during the Poster Session. A notice of acceptance or rejection will be sent via e-mail no later than June 7, 2019. The disposition of each abstract will be sent via e-mail only to the submitting author identified on the submission form for that abstract. That contact will be responsible for sharing the disposition with all other authors of the abstract (including the presenting author).
Accepted abstracts will be in one of two categories:
- Oral Abstract presentation
- Poster Abstract presentation
Presenting authors agree to register for and attend the conference as scheduled in either Oral Abstract sessions or the Poster Session. Oral abstract and poster presenters are responsible for their own travel and accommodation expenses, as well as the applicable registration fees. The Early Registration rate will be made available until 11:59 pm EDT, Friday, July 26, 2019, for presenting authors.
Please note that only the abstracts of paid conference registrants will be included in the final Program and Abstracts Book. Accepted abstracts will be published in the conference proceedings. Abstracts are considered official communication to IAPAC. Submission of an abstract implies permission to publish, and online posting, if accepted. A copy of any electronic presentation and handouts will be transferred to IAPAC.Login or Register to submit an abstract
HIV Nursing 2019 is made possible through sponsorship support from ViiV Healthcare and educational grants from Gilead Sciences and Merck & Co.